This World Diabetes Day, on 14th November, Fitterfly Healthtech and Ascensia Diabetes Care are joining hands to launch a ...

Ascensia is a member of PHC Group and was established in 2016 through the acquisition of Bayer Diabetes Care by PHC Holdings Corporation. Ascensia products are sold in more than 100 countries.

Researchers from organizations with new access to Truveta Data include American Heart Association, Bayer, Edwards Lifesciences ... on topics including colorectal cancer screening, diabetes, and heart ...

Senseonics Holdings, Inc. (NYSE American: SENS), a medical technology company focused on the development and manufacturing of long-term, implantable continuous glucose monitoring (CGM) systems for ...

The global diabetic macular edema market is on a steady growth trajectory, with an expected valuation of approximately USD 4,120.9 million in 2024. The market is poised to surpass USD 4,642.9 million ...

The Indian pharmaceutical market (IPM) registered a 6.1 per cent value growth in October 2024, with major therapies showing ...

With an array of new medicines and medical devices on display, global medical companies are looking to tap further into the ...

Bayer has launched a digital patient support package in England designed to help people with type 2 diabetes look after the health of their kidneys and avoid progression to chronic kidney disease ...

Bayer has claimed EU approval for Kerendia, its new drug for chronic kidney disease (CKD) in people with type 2 diabetes, as the company tries to build a role of the drug alongside rival therapies ...

The global urinary antibacterial and antiseptic pharmaceuticals market is projected to grow at a robust Compound Annual Growth Rate (CAGR) of 4.3% during the forecast period, driven by increasing ...

boosted by its cancer and diabetes medicines, and laid out plans for a multibillion-dollar investment in the U.S. Bayer Cuts Earnings Outlook The pharmaceutical-and-agricultural group lowered its ...